Prevalence and risk factors for hiv among sniffers, short-term injectors, and long-term injectors of heroin

Journal of Psychoactive Drugs

Volumn 35, Issue 4, 2003, Pages 445-453

  Chitwood, Dale D ^a   Comerford, Mary ^a   Sanchez, Jesús ^a  

^a Department of Biology   (United States)

Author keywords

Heroin sniffers; HIV AIDS; Injection drug users; Prevalence; Sex risk

Indexed keywords

DIAMORPHINE;

ADULT; ARTICLE; DRUG ABUSE; FEMALE; HEALTH PROGRAM; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEROPREVALENCE; SEXUAL BEHAVIOR; SNIFFING;

EID: 0347356589     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2003.10400491     Document Type: Article

References (21)

1. Booth, R.E.; Watters, J.K. & Chitwood, D.D. 1993. HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. American Journal of Public Health 83: 1144-48.
2. Chaisson, M.A.; Stoneburner, R.L.; Hildebrandt, D.S.; Ewing, W.E.; Telzak, E.E. & Jaffe, H.W. 1991. Heterosexual transmission ofHIV-1 associated with the use of smokable freebase cocaine (crack). AIDS 5: 1121-26.
3. Chaisson, R.E.; Moss, A.R.; Onishi, R.; Osmond, D. & Carlson, J. 1987. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. American Journal of Public Health 77: 169-72.
4. Chitwood, D.D.; Sanchez, J.; Comerford, M.; Page, J.B.; McBride, D.C. & Kitner, K.R. 2000 First injection and current risk factors for HIV among new and long-term injection drug users. AIDS Care 12(3): 313-20.
5. Chitwood, D. D.; McCoy, C.B.; Comerford, M. & Kitner, K. 1999. The prevalence and incidence of HIV among injection drug users: A five year panel study. Population Research and Policy Review 18: 39-53.
6. Corby, N.H.; Wolitski, R.J.; Thornton-Johnson, S. & Tanner, W. 1991. AIDS knowledge, perception of risk, and behaviors among female sex partners of injection drug users. AIDS Education & Prevention 3: 353-66.
7. Edlin, B.R.; Irwin, K.L.; Ludwig, D.D.; McCoy, H.V.; Serrano, Y.; Word, C.; Bowser, B.P.; Faruque, S.; McCoy, C.B.; Schilling, R.; Holmberg, S.D. & The Multicenter Crack Cocaine and HIV Infection Study Team. 1992. High-risk sex behavior among young street-recruited crack cocaine smokers in three American cities: An interim report. Journal of Psychoactive Drugs 24: 363-71.
8. Gibson, D.R.; McCusker, J. & Chesney, M. 1998. Effectiveness of psychosocial interventions in preventing HIV risk behavior in injecting drug users. AIDS 12: 919-29.
9. Hennekens, C.H. & Buring, J.E. 1987. Epidemiology in Medicine. Boston, Massachusetts: Little, Brown and Company.
10. Hook, E. W. 1989. Syphilis and HIV infection. Journal of Infectious Diseases 160: 530-34.
11. Marmor, M.; Des Jarlais, D.C.; Cohen, H.; Friedman, S.R.; Beatrice, S.T.; El-Sadr, W.; Mildvan, D.; Yancovitz, S.; Mathur, U. & Holzman, R. 1987. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS 1: 39-44.
12. Mascola, L.; Lieb, L.; Iwakoshi, K.A.; McAllister, D.; Siminowski, T.; Giles, M.; Run, G.; Fannin, S.L. & Strantz, I.H. 1989. HIV seroprevalence in intravenous drug users: Los Angeles, California, 1986. American Journal of Public Health 79: 81-2.
13. McCoy, C.B. & Khoury, E. 1990. Druguseandthe riskofAIDS. American Behavioral Scientist 33: 419-31.
14. Neaigus, A.; Miller, M.; Friedman, S.R. & Des Jarlais, D.C. 2001. Sexual transmission risk among non injecting heroin users infected with human immunodeficiency virus or hepatitis C virus. Journal of Infectious Diseases 184: 359-63.
15. Nelson, K.E.; Vlahov, D.; Cohen, S.; Lindsay, A.; Solomon, L. & Anthony, J.C. 1991. Human immunodeficiency virus infection in diabetic intravenous drug users. Journal of the American Medical Association 266: 2259-61.
16. Quinn, T.C.; Cannon, R.O.; Glasser, D.; Groseclose, S.L.; Brathwaite, W.S.; Fauci, A.S. & Hook, E.W. 1990. The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics. Archives of Internal Medicine 150: 1297-302.
17. Schoenbaum, E.E.; Hartel, D.; Selwyn, P.A.; Klein, R.S.; Davenny, K.; Rogers, M.; Feiner, C. & Friedland, G. 1989. Risk factors for human immunodeficiency virus infection in intravenous drug users. New England Journal of Medicine 321: 874-79.
18. Selik, R.; Castro, K.G. & Pappaioanou, M. 1988. Racial/ethnic differences in the risk of AIDS in the United States. American Journal of Public Health 78:1539-45.
19. Tortu, S.; Beardsley, M.; Deren, S. & Davis, W.R. 1994. The risk ofHIV infection in a national sample of women with injection drug-using partners. American Journal of Public Health 84: 1243-49.
20. Vlahov, D.; Munoz, A.; Anthony, J.C.; Cohn, S.; Celentano, D.D. & Nelson, K.E. 1990. Association of drug injection patterns with antibody to human immunodeficiency virus type I among intravenous drug users in Baltimore, Maryland. American Journal of Epidemiology 132: 847-56.
21. Watters, J.K. & Biernacki, P. 1989. Targeted sampling: Options for the study of hidden populations. Social Problems 36:416-30.